Researchers found “no significant discrepancy in safety events” between trastuzumab biosimilars and the originator product.

The most common health-related social needs were employment disruption, loss of income, and lack of sick leave.

Patients with EGFR-mutant, oligometastatic NSCLC who received radiotherapy plus icotinib had longer overall and progression-free survival than those who received icotinib alone.

Democrats and Republicans in statehouses around the country have been working together to tackle the nation’s medical debt crisis.

More than half of US physician peer reviewers for the most influential medical journals receive industry payments, according to research.

Hospitals have been bracing for a nationwide shortage of IV fluids after Hurricane Helene knocked out a North Carolina production plant, but a plant in Daytona Beach, Florida, was spared by Hurricane ...

Half of patients surveyed said they would be less likely to open a patient portal account if they thought their parents would be able to access their medical information.

Baseline circulating tumor cell count “may serve as a valuable, noninvasive biomarker” for patients with metastatic hormone-sensitive prostate cancer, according to researchers.

Some physicians have urged their colleagues and medical societies to move professional conferences out of states that ...

The United States launched the most new cancer drugs during the study period (n=345). Other countries with a high number of launches were Japan (n=224), Canada (n=221), Australia (n=204), the United ...

A machine learning survival model that selects patients for serious illness conversations can increase the rate of advance ...

The FDA has approved Itovebi in combination with palbociclib and fulvestrant to treat certain patients with PIK3CA-mutant breast cancer.